Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TE/RM Product Development-Reference-Cited by-同舟云学术

Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TE/RM Product Development

Published:2015-10 Issue:19-20 Volume:21 Page:2476-2479
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Bertram Timothy A.¹,Johnson Peter C.²,Tawil Bill J.³,Van Dyke Mark⁴,Hellman Kiki B.⁵

Affiliation:

1. RegeMedTX, Winston-Salem, North Carolina.

2. Vancive Medical Technologies, Chicago, Illinois.

3. University of California at Lost Angeles, Los Angeles, California.

4. Virginia Polytechnic Institute and State University, Blacksburg, Virginia.

5. The Hellman Group, Clarksburg, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2015.0136

Reference7 articles.

1. Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Survey of North American Academia and Industry

2. Challenges in Tissue Engineering and Regenerative Medicine Product Commercialization: Building an Industry

3. Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Pilot Survey of Governmental Funding Agencies and the Financial Industry

4. The Regulatory Imperative: International Perspective

5. Awareness of the Role of Science in the FDA Regulatory Submission Process: A Survey of the TERMIS-Americas Membership

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commercialization and regulation of regenerative medicine products: Promises, advances and challenges;Biomedicine & Pharmacotherapy;2022-09

2. New perspectives in regenerative medicine and surgery: the bioactive composite therapies (BACTs);European Journal of Plastic Surgery;2021-10-29

3. Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist—a pragmatic tool to accelerate development of cell therapy products;Stem Cell Research & Therapy;2021-01-29

4. Acellular Biologic Scaffolds in Regenerative Medicine: Unacceptable Variability with Acceptable Results;Regenerative Engineering and Translational Medicine;2019-07-01

5. Stem cell therapy clinical research: A regulatory conundrum for academia;Advanced Drug Delivery Reviews;2017-12